A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
about
CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and DiseaseThe interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicityKiller cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicityChemical Lectinology: Tools for Probing the Ligands and Dynamics of Mammalian Lectins In VivoStructure of Natural Killer Receptor 2B4 Bound to CD48 Reveals Basis for Heterophilic Recognition in Signaling Lymphocyte Activation Molecule FamilyInnate or adaptive immunity? The example of natural killer cellsGlobal unresponsiveness as a mechanism of natural killer cell tolerance in mixed xenogeneic chimeras.Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency.Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44.Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice.NKG2D CARs as cell therapy for cancer.Eosinophil survival and apoptosis in health and disease.IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumoursNK cell-based immunotherapy for malignant diseases.Siglec-mediated regulation of immune cell function in disease.Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK-cell receptor Ly49H.Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.2B4 inhibits NK-cell fratricide.Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ ProductionNK cells promote transplant tolerance by killing donor antigen-presenting cells.Inhibition of immune responses by ITAM-bearing receptors.Immune regulation by SLAM family receptors and SAP-related adaptors.Differential loss of natural killer cell activity in patients with acute myocardial infarction and stable angina pectorisRecruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells.NK cell regulation by SLAM family receptors and SAP-related adapters.Human natural killer cell development.Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse.Licensing of natural killer cells by self-major histocompatibility complex class I.Human natural killer cells.Immune evasion of natural killer cells by viruses.Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cellsActivating killer cell Ig-like receptors in health and disease.Innate immunity and the pathogenesis of type 1 diabetes.Natural killer cell education and tolerance.Unifying concepts of MHC-dependent natural killer cell education.Mechanisms of NK cell activation: CD4(+) T cells enter the scene.The role of natural killer cells in autoimmune blistering diseases.Siglec-8 and Siglec-F, the new therapeutic targets in asthma.
P2860
Q21284814-E535B210-EED9-4005-B7F5-CB4BA676D94AQ24651041-8E5FA18E-48CE-4454-9391-30D8D03F1578Q24676938-A1D552BA-AB02-4461-B0FF-F74C27192F4AQ26800514-8A4D8C34-2475-4B46-B07A-76BCC0B42197Q27648857-26A05C16-1170-4A70-A62E-730CC85D6525Q29615106-4E1AE6E2-B65E-49D3-99C2-EEF0D23FD145Q33291223-717A6F0A-431B-494C-9238-26B59B69F03CQ33302895-9438F83F-0255-481E-9251-4588CAB645AAQ33311287-E21CB161-308C-4EEA-A913-C65F83E8A098Q33474773-2F2EA574-49F8-44A8-8C89-762DBA4C9F67Q33595873-D69C124F-62B1-4D5C-81CD-8C1098ED3A82Q33758139-C6B9A6D0-8E35-4D32-9E08-47FAFD7ECF87Q33786422-D2220B02-8995-405A-9A7D-8D889C035AB8Q33827433-FEB80C7F-5434-4ED4-B621-031923B0C0A2Q34314957-876A9D6C-1094-424D-882E-59D2C53FE210Q34473170-1194BF7A-828C-4422-986A-AC17F4F16616Q34759678-70E4C99A-CD4A-470A-A068-7305ACBE99B7Q34891171-C08B4A33-71B8-4009-B456-FB4FC195415CQ35083496-5F0F06EA-FD64-42D5-A49B-52A630612FDCQ35990641-B6AE375D-878E-495D-B682-4A4582114033Q36143186-8F6D7805-52DB-4C2D-98CE-B24DBCB7F289Q36228823-C1BEC67E-7454-4B2F-8DE6-BFE6FB23E8CFQ36383231-A4B9E6F9-310D-43FA-BAF7-6CAF77BA4F69Q36403407-324BEFB1-9487-47C2-80AD-4B0F52D27B3AQ36464559-86D1A67B-E30A-4EAE-AE4F-FC455B99A83BQ36603122-5FF8492C-A0A1-4956-A9DE-BAE6A7038F73Q36652149-D38F975B-8BCA-4EF8-A415-FB53E6354A88Q36652161-39C81B9B-8BF0-478E-9761-981BEA172747Q36652172-C851010F-A424-4DE1-B203-9332867B4DB3Q36652187-D7599BDB-AD83-4137-AE3B-4D88013B6AABQ36787596-7EF0BB37-B16E-40F1-8D1D-1CFA47352DF9Q37060710-FC4623F5-2D32-417F-9F7C-DE0A744BB7D5Q37256962-81D6D697-DDC4-497A-B86F-7A158D242307Q37725657-8CE80956-E173-4EDA-8BBF-C3D5DD7ED9B6Q37728944-D2434657-9E05-46FD-8FC5-798F00C823A9Q37789866-277656AF-78E4-466D-96BA-46B14CF7CC86Q37900760-082D945A-9CDC-471D-9EA8-FC369B78D843Q37921196-BF25C4F5-F22E-45AE-8B84-37662D5DF379Q37933429-7756EFC4-6840-4C33-9530-D8E3BD91683AQ37983131-8B8D82F2-F9EB-42EA-A9C6-C07414CAC889
P2860
A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
@ast
A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
@en
type
label
A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
@ast
A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
@en
prefLabel
A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
@ast
A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
@en
P2860
P356
P1476
A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
@en
P2093
Megan E McNerney
Vinay Kumar
P2860
P304
P356
10.1038/NRI1603
P577
2005-05-01T00:00:00Z